🇺🇸 FDA
Pipeline program

Natriumthiosulfat 25%

STS-001

Phase 2 small_molecule active

Quick answer

Natriumthiosulfat 25% for Raynaud’s phenomenon is a Phase 2 program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Disc Medicine
Indication
Raynaud’s phenomenon
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials